| 03 Sept, 08:30 pm | kmp_change | 3 | Orchid Pharma Limited appointed a cost auditor and changed the designation of a director. | nse |
| 03 Sept, 08:11 pm | results | 2 | Orchid Pharma Limited reported the outcome of its Board Meeting held on September 03, 2026, which typically involves the approval of quarterly or annual financial results for a company of this size and sector. | nse |
| 24 Aug, 06:23 pm | — | … | Orchid Pharma Limited has informed the Exchange about Transcript | nse |
| 24 Aug, 06:19 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 21 Aug, 08:18 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 21 Aug, 08:16 pm | — | … | Orchid Pharma Limited has informed the Exchange about Link of Recording | nse |
| 20 Aug, 06:09 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 20 Aug, 05:54 pm | — | … | Orchid Pharma Limited has informed the Exchange about Presentation | nse |
| 14 Aug, 08:11 pm | — | … | Orchid Pharma Ltd - 524372 - Statement Of Deviation Or Variation For The Quarter Ended June 30, 2026 On The Use Of Proceeds Of Funds Raised Through Qualified Institutional Placement | bse |
| 14 Aug, 07:03 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 14 Aug, 06:53 pm | — | … | Orchid Pharma Ltd - 524372 - Outcome Of Board Meeting Held For Considering And Approving Revised Audited Financial Results For The Year Ended March 31, 2026 Pursuant To Scheme Of Merger. | bse |
| 14 Aug, 06:51 pm | — | … | Monitoring Agency Report for the Ouarter-I of Financial Year 2026-27, ended on June 30, 2026- Orchid Pharma Limited ("the Company") | nse |
| 14 Aug, 06:43 pm | — | … | Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 14 Aug, 06:41 pm | — | … | Orchid Pharma Ltd - 524372 - Financial Results For Quarter-1 Of F.Y. 2026-27 Ended June 30, 2026. | bse |
| 14 Aug, 06:33 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Outcome Of Board Meeting | bse |
| 14 Aug, 06:31 pm | — | … | Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026. | nse |
| 11 Aug, 05:13 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 14, 2026. | bse |
| 01 Aug, 01:50 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 01 Aug, 01:50 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding allotment of 44586052 securities pursuant to Scheme of Arrangement/Amalgamation at its meeting held on August 01, 2026 | nse |
| 01 Aug, 01:47 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on August 01, 2026. | nse |
| 28 Jul, 06:47 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Prior Intimation Of Board Meeting Scheduled To Be Held On August 01, 2026 | bse |
| 25 Jul, 02:53 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding 'Intimation regarding investor roadshow '. | nse |
| 10 Jul, 08:36 pm | — | … | Orchid Pharma Limited has informed the Exchange that Record date for the purpose of Merger/HiveOff is 23-Jul-2026. | nse |
| 10 Jul, 08:36 pm | — | … | Orchid Pharma Ltd - 524372 - Corporate Action For Fixation Of Record Date | bse |
| 10 Jul, 08:25 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company. | nse |
| 10 Jul, 08:20 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association | bse |
| 10 Jul, 07:43 pm | — | … | Outcome of the Board Meeting: Noting the effect of Scheme of Amalgamation | nse |
| 10 Jul, 07:39 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Intimation Under Regulations 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 As Amended ("SEBI Listing Regulations"). | bse |
| 10 Jul, 07:32 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding 'Update related to the Scheme of Amalgamation of Dhanuka Laboratories Limited ("Amalgamating Company") with Orchid Pharma Limited ("Amalgamated Company/Company") and their respective shareholdersand creditors ("the Scheme") under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), as amended.'. | nse |
| 07 Jul, 07:27 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Jul, 07:27 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding a press release dated 0 , | nse |
| 12 Jun, 12:58 pm | procedural | 0 | Orchid Pharma Limited informed the exchange about general updates with no specific corporate action, financial amount, or material event disclosed. | nse |
| 11 Jun, 03:49 pm | regulatory_action | 0 | Orchid Pharma Limited informed the exchange about action(s) taken or orders passed, with no substantive details disclosed in the headline. | nse |
| 05 Jun, 05:30 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding 'Update on Scheme of Arrangement' that in continuation of our earlier intimations dated March 18, 2026, with respect to the merger petition, we would like to inform that Hon ble National Company Law Tribunal, Chennai ( NCLT ) on June 05, 2026, i.e. today has allowed our petition sanctioning the scheme of Amalgamation and Arrangement of Dhanuka Laboratories Limited with Orchid Pharma Limited and their respective Shareholders and Creditors, | nse |
| 05 Jun, 05:29 pm | — | … | Orchid Pharma Ltd - 524372 - Update Related To The Scheme Of Amalgamation Of Dhanuka Laboratories Limited (''''Amalgamating Company'''') With Orchid Pharma Limited (''''Amalgamated Company'''') And Their Respective Shareholders And Creditors (''''The Scheme'''') Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 01 Jun, 06:41 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 01 Jun, 06:35 pm | — | … | Orchid Pharma Limited has informed the Exchange about Transcript | nse |
| 30 May, 02:46 pm | — | … | Orchid Pharma Ltd - 524372 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 26 May, 07:43 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 26 May, 07:43 pm | — | … | Orchid Pharma Limited has informed the Exchange about Link of Recording | nse |
| 26 May, 02:18 pm | — | … | Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 26 May, 02:14 pm | — | … | Orchid Pharma Limited has informed the Exchange about Investor Presentation | nse |
| 25 May, 09:14 pm | — | … | Orchid Pharma Limited has informed the Exchange regarding Change in Auditors of the company. | nse |
| 25 May, 09:13 pm | — | … | Orchid Pharma Ltd - 524372 - Appointment Of Internal Auditor Of The Company | bse |
| 25 May, 08:33 pm | — | … | Orchid Pharma Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 25 May, 07:58 pm | — | … | Orchid Pharma Ltd - 524372 - Statement Of Deviation Or Variation For The Quarter And Financial Year Ended On March 31, 2026 | bse |
| 25 May, 07:47 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Outcome For Outcome Of Board Meeting For Considering And Approving Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31, 2026 | bse |
| 25 May, 07:36 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Considering And Approving Annual Audited Financial Results For The Quarter And F.Y. Ended On March 31, 2026. | bse |
| 25 May, 07:33 pm | — | … | Orchid Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 19 May, 03:20 pm | — | … | Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Approval Of Audited Financial Results (Standalone & Consolidated) Of The Company For The Quarter-IV And Financial Year Ended On March 31, 2026 | bse |